RTX Corp (RTX) · Oct 20, 2026 · Earnings
Beat — Adjusted EPS $2.26 vs ~$1.78 consensus; sales $24.97B vs ~$24.11B
RTX earnings beat Q3 expectations on broad aerospace and defense growth, while record awards and a higher 2026 outlook reinforce the backlog story.
RTX is operating in a strong aerospace-and-defense cycle: Collins is benefiting from commercial aircraft production and aftermarket demand, Pratt & Whitney is monetizing its GTF installed base while working through engine-related issues, and Raytheon is seeing volume growth across missile and air-defense programs. The prior quarter already showed record backlog and a raised 2026 outlook, so the broad direction was known; this filing adds a stronger-than-expected quarter and another outlook increase.
| Metric | Q3 2026 | Q3 2025 / expectation | Read |
|---|---|---|---|
| Sales | $24.97B | $22.48B; ~$24.11B consensus | 11% reported growth; above consensus |
| Adjusted EPS | $2.26 | $1.70; ~$1.78 consensus | 33% growth; clear beat |
| GAAP EPS | $1.89 | $1.41 | 34% growth |
| Operating cash flow | $2.87B | $4.64B | Down 38% |
| Free cash flow | $2.12B | $4.03B | Down 47% |
| Record backlog | $340B | Not comparable | Up from the prior disclosed $289B backlog |
The quarter beat on the measures the market usually anchors to. Adjusted EPS of $2.26 was well above the published consensus of roughly $1.78, while sales of $24.965 billion exceeded the roughly $24.11 billion expectation. The result was broad rather than dependent on one segment: organic sales rose 12% companywide, with Collins up 12%, Pratt & Whitney up 10%, and Raytheon up 14%.
The operating engine is improving across all three businesses, but Pratt remains the complication. Collins delivered a 50% increase in adjusted operating profit and Raytheon grew adjusted operating profit 32%, supported by commercial volume, aftermarket demand, defense programs, productivity, and favorable mix. Pratt’s reported profit fell 19% because of a $363 million customer-bankruptcy charge, but adjusted profit rose 29%; that makes the underlying quarter much better than the headline Pratt number, while also showing that unusual exposures have not disappeared.
The backlog and awards materially strengthen the growth narrative. RTX cited more than $81 billion of new commercial and defense awards and a record $340 billion backlog, up from the $289 billion disclosed after the second quarter. That supports the view that demand is not merely a one-quarter spike; the execution question is increasingly about production, capacity, and converting orders into cash.
Cash conversion is the main offset, and it is too large to ignore. Free cash flow fell to $2.1 billion from $4.0 billion, while operating cash flow dropped to $2.9 billion from $4.6 billion. The filing attributes part of the quarter’s cash generation to a $0.3 billion IEEPA recovery, so the beat is stronger on earnings and demand than on underlying cash delivery.
Management raised the full-year outlook again, turning a strong quarter into a higher forward bar. The filing says sales, adjusted EPS, and free cash flow guidance were raised, building on the prior quarter’s increase. Exact revised ranges are not included in the supplied filing text, so the direction is clear but the size of the increase cannot be assessed here. 〔0〕
Bottom line: This is a genuine earnings beat that advances RTX’s central story: strong aerospace and defense demand is translating into growth and another outlook raise. The weaker cash flow and Pratt’s bankruptcy charge temper the quality of the quarter, but they do not outweigh the breadth of the operating improvement and backlog expansion.
Q4 earnings and final 2026 results, late January 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!